Innovax-ILT

Authorised

This medicine is authorised for use in the European Union

avian infectious laryngotracheitis and Marek’s disease vaccine (live)

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website. 

Innovax-ILT : EPAR - Summary for the public

Product information

Innovax-ILT : EPAR - Product Information

Innovax-ILT : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Innovax-ILT
• Active substance:
  cell-associated live recombinant turkey herpesvirus (strain HVT/ILT-138), expressing the glycoproteins gD and gI of infectious laryngotracheitis virus
• International non-proprietary name (INN) or common name:
  avian infectious laryngotracheitis and Marek’s disease vaccine (live)

Authorisation details

• EMA product number:
  EMEA/V/C/003869

Assessment history

Changes since initial authorisation of medicine

Innovax-ILT : EPAR - Procedural steps taken and scientific information after authorisation

Initial marketing authorisation documents

Innovax-ILT : EPAR - Public assessment report

Adopted Reference Number: EMA/309739/2015

CVMP summary of positive opinion for Innovax-ILT

Adopted Reference Number: EMA/235978/2015